137 results on '"Leibovitzh, Haim"'
Search Results
2. IL-12 and IL-23 pathway inhibition in inflammatory bowel disease
3. Faecal Transplantation for Ulcerative Colitis From Diet Conditioned Donors Followed by Dietary Intervention Results in Favourable Gut Microbial Profile Compared to Faecal Transplantation Alone.
4. The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial
5. Early Indolent Course of Crohn’s Disease in Newly Diagnosed Patients Is Not Rare and Possibly Predictable
6. Anti-microbial antibody response is associated with future onset of Crohn’s disease independent of biomarkers of altered gut barrier function, subclinical inflammation, and genetic risk
7. Specialized Emergency Department Assessment and Multidisciplinary Intervention After Discharge Improve Management of Patients With Inflammatory Bowel Diseases
8. Autoimmune Pancreatitis in Patients with Inflammatory Bowel Disease: A Real-World Multicentre Collaborative ECCO CONFER Study
9. Anti-Saccharomyces cerevisiae antibodies predict severe liver disease and advanced fibrosis in patients with primary sclerosing cholangitis and inflammatory bowel disease
10. Smoking increases the likelihood of Helicobacter pylori treatment failure
11. Understanding Predictors of Crohn's Disease: Determinants of Altered Barrier Function in Pre-Disease Phase of Crohn's Disease.
12. Autoimmune pancreatitis in patients with inflammatory bowel disease - a real-world multicentre collaborative ECCO CONFER study
13. Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn's disease highlight earliest events of pathogenesis
14. Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn’s disease highlight earliest events of pathogenesis
15. Reply
16. Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn’s Disease
17. Mediterranean-Like Dietary Pattern Associations With Gut Microbiome Composition and Subclinical Gastrointestinal Inflammation
18. Helicobacter pylori infection is positively associated with an increased BMI, irrespective of socioeconomic status and other confounders: a cohort study
19. Mo1515: THE TRANSCRIPTOMIC PROFILE OF THE NON-INFLAMED ILEUM IN CROHN’S DISEASE DIFFERS COMPARED TO THAT OF HEALTH CONTROLS
20. Tu1492: ILEAL MICROBIOME REMAINS LESS DIVERSE IN ENDOSCOPICALLY AND HISTOLOGICALLY INACTIVE CROHN'S DISEASE COMPARED TO ULCERATIVE COLITIS OR HEALTHY CONTROLS
21. Mo1506: LOWER SERUM CONCENTRATION OF SULFATED BILE ACIDS IS ASSOCIATED WITH PRIMARY SCLEROSING CHOLANGITIS INFLAMMATORY BOWEL DISEASE COMORBIDITY AND ADVANCED LIVER FIBROSIS
22. 793: ENVIRONMENTAL FACTORS ASSOCIATED WITH RISK OF CROHN'S DISEASE DEVELOPMENT IN A PROSPECTIVE COHORT OF HEALTHY FIRST-DEGREE RELATIVES OF CD PATIENTS
23. Sa1583: SERUM PROTEOMIC MARKERS THAT PREDICT FUTURE CROHN'S DISEASE DEVELOPMENT ARE ASSOCIATED WITH GUT BARRIER FUNCTION, SUBCLINICAL GUT INFLAMMATION AND IMMUNE RESPONSE TO BACTERIAL ANTIGENS
24. 1091 ASSOCIATION OF AIR POLLUTION WITH RISK OF CROHN'S DISEASE AND BIOMARKERS OF CD RISK IN THE CCC-GEM PROJECT
25. Tu1835 COMPARATIVE EFFECTIVENESS AND SAFETY OF INFLIXIMAB AND TACROLIMUS IN THE TREATMENT OF ACUTE SEVERE ULCERATIVE COLITIS
26. 27 DEVELOPMENT AND VALIDATION OF AN INTEGRATED RISK SCORE FOR PREDICTING FUTURE RISK OF CROHN'S DISEASE UP TO 7 YEARS BEFORE DIAGNOSIS IN HEALTHY FIRST-DEGREE RELATIVES: THE CCCGEM PROJECT, A MULTICENTRE PROSPECTIVE COHORT STUDY
27. Relationship between homocysteine and intraocular pressure in men and women: A population-based study
28. Environmental Factors Associated With Risk of Crohn's Disease Development in the Crohn's and Colitis Canada - Genetic, Environmental, Microbial Project.
29. 601 INTESTINAL PERMEABILITY IN HEALTHY FIRST-DEGREE RELATIVES OF CROHN'S DISEASE PATIENTS IS ASSOCIATED WITH ENVIRONMENTAL AND DEMOGRAPHIC FACTORS RATHER THAN CROHN'S DISEASE POLYGENIC RISK SCORE
30. Dose‐dependent association of proton pump inhibitors use with gastric intestinal metaplasia among Helicobacter pylori‐positive patients
31. sj-pdf-1-ueg-10.1177_2050640620951403 - Supplemental material for Dose-dependent association of proton pump inhibitors use with gastric intestinal metaplasia among Helicobacter pylori-positive patients
32. sj-pdf-1-ueg-10.1177_2050640620951400 - Supplemental material for Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study
33. WED-291 - Anti-Saccharomyces cerevisiae antibodies predict severe liver disease and advanced fibrosis in patients with primary sclerosing cholangitis and inflammatory bowel disease
34. Specialized Emergency Department Assessment and Multidisciplinary Intervention After Discharge Improve Management of Patients With Inflammatory Bowel Diseases
35. Sa1799 IL-23 RECEPTOR GENETIC VARIANTS ASSOCIATIONS WITH GUT BARRIER FUNCTION AND MICROBIOME COMPOSITON IN A COHORT OF HEALTY FIRST-DEGREE RELATVIES OF SUBJECTS WITH CROHN'S DISEASE
36. 1233 BILE ACID COMPOSITION, DIETARY FAT, AND CROHN'S DISEASE RISK
37. 1236 FIRST-DEGREE RELATIVES OF PATIENTS WITH CROHN'S DISEASE FROM MULTIPLEX FAMILIES ARE THREE TIMES MORE LIKELY TO DEVELOP DISEASE AND THIS RISK IS ASSOCIATED WITH SUBCLINICAL INFLAMMATION AND ALTERED MICROBIOME COMPOSITION, BUT NOT GENETIC BURDEN
38. 962 EARLY LIFE EXPOSURE TO PARENTAL CROHN'S DISEASE IS ASSOCIATED WITH ALTERED GUT MICROBIOME COMPOSITION, IMPAIRED GUT PERMEABILITY, AND INCREASED RISK OF INCIDENT CROHN'S DISEASE
39. 828 SERUM METABOLOMICS IDENTIFIES DYSREGULATED PATHWAYS AND POTENTIAL METABOLIC BIOMARKERS INVOLVED IN DEVELOPMENT OF CROHN'S DISEASE
40. 634 DIETARY ASSOCIATIONS WITH METABOLITES IMPLICATED WITH CROHN'S DISEASE RISK
41. Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study
42. Sa1773 POST-OPERATIVE PROPHYLAXIS WITH ANTI-TNF IN PATIENTS WITH CROHN'S DISEASE WHO ARE ANTI-TNF EXPERIENCED IS ASSOCIATED WITH HIGHER RATES OF PROPHYLAXIS FAILURE
43. Mo1121 TARGETED MUCOSAL TRANSCRIPTOMICS ANALYSIS REVEALS DIFFERENTIAL EXPRESSION OF CARNITINE, TRIMETHYLAMINE AND TRIMETHYLAMINE-N-OXIDE GENE PATHWAYS IN INFLAMMATORY BOWEL DISEASE
44. Sa1753 – IBD Nurse Intervention for Patients Assigned to Biologic Therapy Decreases Uncertainty and Improves Patients' Reported Outcomes
45. Mo1766 – Multidisciplinary Team Care At the Emergency Department Contributes to Improved Management of Patients with Inflammatory Bowel Diseases
46. The compliance rate for the second diagnostic evaluation after a positive fecal occult blood test: A systematic review and meta‐analysis
47. Optimization of 13 C-urea breath test threshold levels for the detection of Helicobacter pylori infection in a national referral laboratory
48. Mo1657 - The Compliance Rate for the Second Diagnostic Evaluation after a Positive Fecal Occult Blood Test - Systematic Review and Meta-Analysis
49. Su1218 - Disparities in Helicobacter Pylori Prevalencve Rate According to Socioeconomic Status, Country of Birth and Trends over Time in Adults Performing 13 C-Urea Breath Test at the Largest Israeli Health Maintenance Organization
50. Temporal Trends in Helicobacter pylori Eradication Success in a Test-and-Treat Population
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.